2018 American Transplant Congress » Poster Session B: Heart and VADs: All Topics

Date: Sunday, June 3, 2018

Time: 6:00pm-7:00pm

Location: Hall 4EF

Session Type: Poster Session

Meeting: 2018 American Transplant Congress

6:00pm-7:00pm: Air Pollution Can Support the Development of Cardiac Allograft Vasculopathy

C. Bara,¹ M. Barten,² D. Boethig,¹ Y. Scheibner,¹ J. Tauber,² H. Reichenspurner,² A. Haverich.¹

6:00pm-7:00pm: Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients

S. Amdani, A. Dalal, K. Simpson, J. Scheel, A. Abarbanell, P. Eghtesady, C. Canter, C. Castleberry.

6:00pm-7:00pm: Assessing Response to Desensitization: What Makes Sense?

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Cardiac MRI May Help to Determine When to Refer Heart Transplant Patients for Redo Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Chronic Narcotic Use Increases Mortality Rates in Heart Transplantation

G. St. John, T. Chamogeorgakis, H. Nemeh, C. Tita, Y. Selektor, D. Lanfear, C. Williams.

6:00pm-7:00pm: Combined Heart–Kidney Compared to Isolated Heart Transplant in Patients with Chronic Kidney Disease – A Single Center Experience

D. Gauvin, A. Bhalla, W. McCallum, A. Vest, N. Goyal.

6:00pm-7:00pm: Congestive Hepatic Fibrosis: Correlation with Cardiac Hemodynamics and Changes after VAD or Cardiac Transplant

S. Dhingra,¹ A. Segura,³ N. Cortes-Santiago,¹ M. Schwartz,⁵ S. Mittal,⁴ P. Jalal,² G. Sood.²

6:00pm-7:00pm: Decreased Post Heart Transplant Survival with Epstein-Barr Virus Mismatch in the Current Era

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, S. Mersola, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Deep Vein Thrombosis in Heart Transplant Patients

G. Bhat, T. Setia, C. Nguyen, I. Balanlayos, A-.G. Roska, A. Andrade, W. Cotts, G. Macaluso, S. Pauwaa, M. Bresticker, A. Tatooles, P. Pappas.

6:00pm-7:00pm: Early Adjunctive Treatment with Human Cytomegaly Virus (CMV) Immunoglobulin Increased CMV-Free Survival after Heart Transplantation

M. Barten,¹ C. Neumaier,¹ A. Bernhardt,¹ M. Rybczynski,² R. Plaetke,³ H. Reichenspurner.¹

6:00pm-7:00pm: Extracorporeal Membrane Oxygenation Experience for Graft Failure after Heart Transplantation

S. Lehmann, K. Jawad, S. Feder, A. Meyer, M. Dieterlen, J. Fischer, J. Garbade, M. Borger.

6:00pm-7:00pm: Geographic Variation in the Treatment of Adult Heart Transplant Candidates in the US

W. Parker,¹ M. Churperk,¹ D. Hedeker,¹ E. Huang,¹ E. Garrity,¹ M. Siegler,¹ A. Anderson.²

6:00pm-7:00pm: Heart Transplant across Low or Moderate Level Donor-Specific Antibodies Have Acceptable Outcome

M. Olymbios, J. Patel, R. Levine, S. Dimbil, M. Kittleson, M. Rafiei, X. Zhang, J. Kobashigawa.

6:00pm-7:00pm: Heart Transplantation in Patients with Complex Congenital Heart Disease

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa, R. Garg, E. Zahn.

6:00pm-7:00pm: Hemodynamic and Functional Analysis of Human DCD Hearts Undergoing Normothermic Ex Vivo Perfusion

W. Sommer, N. Roy, S. Kilmarx, J. O., J. Titus, M. Villavicencio, J. Stone, J. Madsen, D. D'Alessandro.

6:00pm-7:00pm: IVIG Induction May Be Helpful in Highly Sensitized Patients after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Impact of Pre-Transplant Non-Dialysis Renal Dysfunction in Heart Transplant Recipients on Post-Transplant ESRD: A UNOS Database Analysis

S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.

6:00pm-7:00pm: Impact of Sleep Apnea Syndrome on Late Graft Dysfunction

A. Afzal,¹ K. Tecson,² A. Jamil,³ A. Wazir,¹ J. Felius,³ H. Qin,³ P. Garcha,¹ S. Carey,¹ S. Hall.¹

6:00pm-7:00pm: Incidence of Pneumonitis in Heart Transplant Patients Started on a Proliferation Signal Inhibitor

R. Levine, J. Patel, M. Levine, M. Kittleson, E. Kransdorf, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Increased Length of Stay of the Donor Decreases Heart Transplant Recipient Survival

H. Copeland,¹ R. Talluri,² A. Panos,¹ R. Cochran,¹ L. Creswell,¹ D. Baran.³

6:00pm-7:00pm: Institution-Based, Pharmacist-Managed Anticoagulation in Patients with a Left Ventricular Assist Device

T. Bibb,¹ L. Halder,¹ D. McDanel,¹ A. Briasoulis,² P. Alvarez,² K. Horner,¹ J. Bhama,³ S. Larson.³

6:00pm-7:00pm: Is Renal Function after Heart Transplantation an Issue for Patients with Cardiac Amyloidosis?

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Kidney Graft Outcomes in Combined Heart-Kidney Transplantation: A UNOS Database Analysis 2000-2015

A. Riaz, O. Adebiyi, D. Mishler, M. Yaqub, T. Taber, A. Sharfuddin.

6:00pm-7:00pm: Late Donor-Specific Antibody (Especially Class II) Development is Associated with an Increased Risk for Cardiac Allograft Vasculopathy

E. Kransdorf, J. Patel, M. Kittleson, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Left Ventricular Assist Devices Complicated by Gastrointestinal Bleeding and Outcomes on Transplant

L. Aurora, O. Sadiq, H. Nemeh, C. Williams.

6:00pm-7:00pm: Less Induction Therapy Means Fewer Early Readmissions with No Change in Rejection or Infection

S. Kush, K. Boyle, J. Gray, S. Rega, I. Feurer, A. Shah, J. Lindenfeld.

6:00pm-7:00pm: Liver Biopsy Fibrosis Not Liver Imaging Predicts Survival after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Long-Term Success of Treatment for Cardiac Transplant AMR May Depend Upon Suppressing Class II Donor Specific Antibodies

J. Hofmann,¹ D. Weisshaar,² D. Kiprov.³

6:00pm-7:00pm: Lymphocyte Proportions Post Thymectomy Are Associated with Allergic Disorders in Heart Transplanted Children

T. Kim,¹ L. Ionescu,^1,2,3 N. Avdimiretz,⁴ M. Larsen,^1,2,3 F. Murdoch,^1,2 B. Motyka,^1,2,3 S. Gilmour,^1,2 L. West,^1,2,3 S. Urschel.^1,2,3

6:00pm-7:00pm: MCS and Desensitization

J. Kobashigawa, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, E. Passano, L. Czer, J. Moriguchi, F. Arabia.

6:00pm-7:00pm: Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era

X. Zeng,¹ R. Vela,² J. Pruszynski,² J. Martinez,² S. Ring,² M. Peltz.²

6:00pm-7:00pm: Outcomes of Subsequent Pregnancies in Female Heart Transplant Recipients

S. Rao,^1,2 D. Armenti,¹ L. Coscia,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4

6:00pm-7:00pm: Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Renal-Sparing Protocol May Be Harmful If Performed Early Post-Heart Transplant

J. Patel, M. Johl, E. Kransdorf, M. Kittleson, S. Dimbil, R. Levine, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Risk of Infection in Treatment of Acute Cellular Rejection in Heart Transplant Recipients

T. Fallah, A. Logan, A. Rumore, C. Doligalski.

6:00pm-7:00pm: Safety and Efficacy of Rabbit Anti-Thymocyte Globulin Induction in Pediatric Patients Undergoing Cardiac Transplantation

M. Sell,¹ A. Haney,¹ K. Sprott,¹ A. Burnette,² H. Henderson,² A. Savage.²

6:00pm-7:00pm: Single vs. Multi-Drug Antibiotic Prophylaxis for Continuous-Flow Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis

S. Patel,¹ J. Choi,¹ E. Moncho Escrivà,² S. Rizvi,¹ L. Samuels,¹ J. Luc,³ R. Morris,¹ H. Massey,¹ V. Tchantchaleishvili,¹ N. Aburjania.⁴

6:00pm-7:00pm: The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: The Continuous Debate of Older Donors into Older Recipients: Another Angle

J. Patel, M. Kittleson, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: The Overriding Importance of HLA-DR Donor-Specific Antibody That is Correlated to CAV after Heart Transplant

E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: The Renal Sparing Protocol after Heart Transplant That Keeps Giving

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, R. Sharoff, J. Kobashigawa.

6:00pm-7:00pm: The Secret is Selection of Muscular Dystrophy for Success after Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

6:00pm-7:00pm: Urinary Cell Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

S. Joseph, H. Medel-Martinez, T. Bottiglieri, B. Wasek, S. Yeramaneni, J. Felius, C. Bonilla, O. Sido, C. Gottlich, B. Lima, S. Hall.

6:00pm-7:00pm: What Threshold MFI is the Luminex 1:8 Dilution the Poor Man's C1q for Patients Awaiting Heart Transplant?

M. Kittleson, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

« View all sessions from the 2018 American Transplant Congress